GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Agt | affects expression | EXP | | 6480464 | CTD | bisphenol A affects the expression of AGT mRNA | PMID:30903817 | Agt | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of AGT mRNA | PMID:25181051 | Agt | increases expression | EXP | | 6480464 | CTD | bisphenol A results in increased expression of AGT mRNA; bisphenol A results in increased expression of AGT protein | PMID:30677511 PMID:32145629 PMID:38027817 | Agt | multiple interactions | EXP | | 6480464 | CTD | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of AGT mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of AGT protein]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in increased expression of AGT mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in increased expression of AGT protein]; [icatibant co-treated with Captopril] inhibits the reaction [bisphenol A results in increased expression of AGT protein]; bisphenol A inhibits the reaction [Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of and results in increased secretion of AGT protein modified form]]; Captopril inhibits the reaction [bisphenol A results in increased expression of AGT protein]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of AGT mRNA]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of AGT protein]; Losartan inhibits the reaction [bisphenol A results in increased expression of AGT protein] | PMID:30677511 PMID:32319667 PMID:38027817 | Agt | affects expression | ISO | AGT (Homo sapiens) | 6480464 | CTD | bisphenol A affects the expression of AGT mRNA | PMID:30903817 | Agt | increases expression | ISO | Agt (Mus musculus) | 6480464 | CTD | bisphenol A results in increased expression of AGT mRNA; bisphenol A results in increased expression of AGT protein | PMID:25103225 PMID:30951980 | Agt | increases expression | ISO | AGT (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased expression of AGT mRNA; bisphenol A results in increased expression of AGT protein | PMID:27685785 PMID:30677511 PMID:36828454 | Agt | increases methylation | ISO | Agt (Mus musculus) | 6480464 | CTD | bisphenol A results in increased methylation of AGT promoter | PMID:27312807 | Agt | multiple interactions | ISO | AGT (Homo sapiens) | 6480464 | CTD | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in increased expression of AGT mRNA]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of AGT mRNA] | PMID:30677511 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |